US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PELTHOS THERAPEUTICS INC

25.51

-1.1500-4.31%

Post-market: 25.510.00000.00%19:30 EDT

Volume:21.64K

Turnover:569.12K

Market Cap:97.67M

PE:-0.97

High:28.47

Open:26.41

Low:25.00

Close:26.66

52wk High:37.50

52wk Low:18.19

Shares:3.83M

Float Shares:1.07M

Volume Ratio:0.93

T/O Rate:2.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-26.3603

EPS(LYR):-23.0359

ROE:-333.84%

ROA:-49.98%

PB:-65.07

PE(LYR):-1.11

Loading ...

Overview Company News Filings

Pelthos Therapeutics (PTHS) Receives a Buy from Alliance Global Partners

Pelthos Therapeutics Added to Russell 3000e™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes

THOMSON REUTERS

Pelthos Therapeutics director Todd C. Davis buys USD 999,994 of common stock

Alliance Global Partners Remains a Buy on Pelthos Therapeutics (PTHS)

Pelthos Therapeutics (PTHS) Receives a Buy from Alliance Global Partners

Pelthos Therapeutics CEO to present at Jefferies Global Healthcare Conference

Pelthos Therapeutics CFO, Treasurer and Secretary Francis Knuettel II disposes of USD 40,265 in common shares

Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX), Bristol-Myers Squibb (BMY) and Pelthos Therapeutics (PTHS)

Pelthos Therapeutics replaces auditor CBIZ with Grant Thornton

Lake Street Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)

H.C. Wainwright Remains a Buy on Pelthos Therapeutics (PTHS)

Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS) and Pelthos Therapeutics (PTHS)

Pelthos Q1 FY26 net loss widens to $10.24 million; revenue rises to $10.91 million

Pelthos Therapeutics Announces First Quarter 2026 Financial Results

THOMSON REUTERS

Pelthos Therapeutics Inc - Q1 2026 Net Loss Narrows to $10.2 Mln

THOMSON REUTERS

Wall Street Analysts Are Bullish on Top Healthcare Picks

Pelthos Therapeutics to report first-quarter results, host conference call

Alliance Global Partners Keeps Their Buy Rating on Pelthos Therapeutics (PTHS)

Pelthos Therapeutics files Form 3 for CFO John M. Gay

Pelthos CEO to hold investor meetings at Piper Sandler Spring Biopharma Symposium

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PTHS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":25.51,"timestamp":1787342400000,"preClose":26.66,"halted":0,"volume":21635,"hourTrading":{"tag":"盘后","latestPrice":25.51,"preClose":25.51,"latestTime":"19:30 EDT","volume":124,"amount":3163.24,"timestamp":1787355007026,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.043135783945986446,"floatShares":1065500,"shares":3828500,"eps":-26.360256,"marketStatus":"Market Closed","change":-1.15,"latestTime":"08-21 16:00:00 EDT","open":26.41,"high":28.4731,"low":25,"amount":569123.9060399999,"amplitude":0.130274,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.360256,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":26.66,"postHourTrading":{"tag":"盘后","latestPrice":25.51,"preClose":25.51,"latestTime":"19:30 EDT","volume":124,"amount":3163.24,"timestamp":1787355007026,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9347187410915764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":1065500,"roa":"-49.98%","roe":"-333.84%","lyrEps":-23.035919,"volumeRatio":0.9347187410915764,"shares":3828500,"dividePrice":0,"high":28.4731,"amplitude":0.130274,"preClose":26.66,"low":25,"week52Low":18.19,"pbRate":"-65.07","psRate":"2.26","week52High":37.5,"institutionHeld":0,"latestPrice":25.51,"eps":-26.360256,"divideRate":0,"volume":21635,"delay":0,"ttmEps":-26.360256,"open":26.41,"prevYearClose":31,"prevWeekClose":27.5,"prevMonthClose":28.66,"prevQuarterClose":28.26,"fiveDayClose":27.5,"twentyDayClose":25.92,"sixtyDayClose":26.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PTHS","fiscalQuarterEnding":"2026/06","expectedEps":-3.02,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-6.62},{"market":"US","date":"2026-05-14","symbol":"PTHS","fiscalQuarterEnding":"2026/03","expectedEps":4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-3.09},{"market":"US","date":"2026-03-19","symbol":"PTHS","fiscalQuarterEnding":"2025/12","expectedEps":-3.95,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-2.83},{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1775102400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2026-08-21","current":-0.967745,"percent":0.985965,"low":-12.702408,"twenty":-4.332389,"median":-2.094939,"eighty":-1.781447,"high":-1.038767,"avg":-3.932093,"sd":3.341943,"marketCap":102066983},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-05","current":-3.422448,"twenty":-11.024224,"median":-7.763609,"eighty":-1.805104,"marketCap":80705911},{"date":"2025-12-12","current":-3.133628,"twenty":-10.952193,"median":-4.332389,"eighty":-1.816843,"marketCap":73895143},{"date":"2025-12-19","current":-2.967391,"twenty":-10.936709,"median":-3.83078,"eighty":-1.833421,"marketCap":69975058},{"date":"2025-12-26","current":-3.468719,"twenty":-10.936036,"median":-3.687312,"eighty":-1.856092,"marketCap":81797046},{"date":"2026-01-02","current":-4.057747,"twenty":-10.93065,"median":-3.642809,"eighty":-1.874014,"marketCap":95687111},{"date":"2026-01-09","current":-3.672916,"twenty":-10.883527,"median":-3.665062,"eighty":-1.88181,"marketCap":86612268},{"date":"2026-01-16","current":-3.395418,"twenty":-10.806109,"median":-3.583058,"eighty":-1.88647,"marketCap":80068505},{"date":"2026-01-23","current":-3.187295,"twenty":-10.776489,"median":-3.555764,"eighty":-1.893817,"marketCap":75160682},{"date":"2026-01-30","current":-3.374475,"twenty":-10.771103,"median":-3.506679,"eighty":-1.898477,"marketCap":79574636},{"date":"2026-02-06","current":-3.052604,"twenty":-10.742156,"median":-3.468719,"eighty":-1.919625,"marketCap":71984487},{"date":"2026-02-13","current":-2.833747,"twenty":-10.623674,"median":-3.435432,"eighty":-1.954036,"marketCap":66823556},{"date":"2026-02-20","current":-3.036408,"twenty":-10.612903,"median":-3.401675,"eighty":-1.95977,"marketCap":71602566},{"date":"2026-02-27","current":-3.155779,"twenty":-10.602805,"median":-3.390837,"eighty":-1.970524,"marketCap":74417489},{"date":"2026-03-06","current":-3.074826,"twenty":-10.434506,"median":-3.374475,"eighty":-1.97142,"marketCap":72508518},{"date":"2026-03-13","current":-3.190081,"twenty":-10.434506,"median":-3.360076,"eighty":-1.972316,"marketCap":75226374},{"date":"2026-03-20","current":-1.7154,"twenty":-10.097909,"median":-3.349516,"eighty":-1.97142,"marketCap":74309421},{"date":"2026-03-27","current":-1.761468,"twenty":-9.761313,"median":-3.316998,"eighty":-1.911381,"marketCap":76305047},{"date":"2026-04-02","current":-1.649924,"twenty":-9.626674,"median":-3.312954,"eighty":-1.88181,"marketCap":71473065},{"date":"2026-04-10","current":-1.749075,"twenty":-9.525695,"median":-3.297807,"eighty":-1.833421,"marketCap":75768160},{"date":"2026-04-17","current":-1.781608,"twenty":-9.500787,"median":-3.280885,"eighty":-1.792379,"marketCap":77177489},{"date":"2026-04-24","current":-1.797101,"twenty":-9.439526,"median":-3.26405,"eighty":-1.781608,"marketCap":77848597},{"date":"2026-05-01","current":-1.936531,"twenty":-9.424716,"median":-3.220673,"eighty":-1.782538,"marketCap":83888575},{"date":"2026-05-08","current":-1.938855,"twenty":-9.37086,"median":-3.190081,"eighty":-1.785296,"marketCap":83989241},{"date":"2026-05-15","current":-2.144901,"twenty":-9.354703,"median":-3.188002,"eighty":-1.78619,"marketCap":92914985},{"date":"2026-05-22","current":-1.825776,"twenty":-9.310946,"median":-3.162639,"eighty":-1.782538,"marketCap":94189979},{"date":"2026-05-29","current":-1.738193,"twenty":-9.201215,"median":-3.155779,"eighty":-1.782305,"marketCap":89671641},{"date":"2026-06-05","current":-1.742235,"twenty":-9.106968,"median":-3.138864,"eighty":-1.781608,"marketCap":89880179},{"date":"2026-06-12","current":-1.934919,"twenty":-9.053119,"median":-3.057709,"eighty":-1.781608,"marketCap":99820524},{"date":"2026-06-18","current":-1.819713,"twenty":-9.002347,"median":-3.051164,"eighty":-1.781608,"marketCap":93877171},{"date":"2026-06-26","current":-1.967931,"twenty":-8.742683,"median":-3.016477,"eighty":-1.781608,"marketCap":101523590},{"date":"2026-07-02","current":-1.886411,"twenty":-8.328756,"median":-3.009278,"eighty":-1.781608,"marketCap":97318060},{"date":"2026-07-10","current":-1.829819,"twenty":-7.979401,"median":-2.945794,"eighty":-1.781608,"marketCap":94398518},{"date":"2026-07-17","current":-1.799501,"twenty":-7.934399,"median":-2.91896,"eighty":-1.781608,"marketCap":92834477},{"date":"2026-07-24","current":-1.91336,"twenty":-7.821168,"median":-2.887545,"eighty":-1.781608,"marketCap":98708318},{"date":"2026-07-31","current":-1.76851,"twenty":-7.788854,"median":-2.833747,"eighty":-1.781608,"marketCap":91235681},{"date":"2026-08-07","current":-1.9841,"twenty":-7.738365,"median":-2.592541,"eighty":-1.781608,"marketCap":102357745},{"date":"2026-08-14","current":-1.950414,"twenty":-7.559968,"median":-2.325379,"eighty":-1.781608,"marketCap":100619922},{"date":"2026-08-21","current":-1.18144,"twenty":-4.332389,"median":-2.094939,"eighty":-1.781447,"marketCap":102066983}],"updateTime":1787458284677},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649162938","title":"Pelthos Therapeutics (PTHS) Receives a Buy from Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2649162938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649162938?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:35","pubTimestamp":1783337741,"startTime":"0","endTime":"0","summary":"In a report released today, James Molloy from Alliance Global Partners reiterated a Buy rating on Pelthos Therapeutics, with a price target of $75....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-receives-a-buy-from-alliance-global-partners-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-receives-a-buy-from-alliance-global-partners-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648564166","title":"Pelthos Therapeutics Added to Russell 3000e™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564166?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:27","pubTimestamp":1782851268,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN43216O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643593789","title":"Pelthos Therapeutics director Todd C. Davis buys USD 999,994 of common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2643593789","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643593789?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:26","pubTimestamp":1781558761,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics director Todd C. Davis bought 35,948 common shares at weighted-average prices of USD 27.8 and USD 28.73.His directly held stake rose to 75,834 shares.The filing also lists 1.5 million shares held indirectly through Ligand Pharmaceuticals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDLbsXLnB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","PTHS","BK4139","LGND","LU0566484027.USD","BK4007","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643965208","title":"Alliance Global Partners Remains a Buy on Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643965208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643965208?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:37","pubTimestamp":1781523477,"startTime":"0","endTime":"0","summary":"Alliance Global Partners analyst James Molloy reiterated a Buy rating on Pelthos Therapeutics today and set a price target of $75.00. Molloy covers...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-remains-a-buy-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-remains-a-buy-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641930481","title":"Pelthos Therapeutics (PTHS) Receives a Buy from Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2641930481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641930481?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:55","pubTimestamp":1780919714,"startTime":"0","endTime":"0","summary":"Alliance Global Partners analyst James Molloy reiterated a Buy rating on Pelthos Therapeutics today and set a price target of $75.00. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-receives-a-buy-from-alliance-global-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-receives-a-buy-from-alliance-global-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639619796","title":"Pelthos Therapeutics CEO to present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2639619796","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639619796?lang=en_us&edition=fundamental","pubTime":"2026-05-29 05:00","pubTimestamp":1780002021,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics CEO Scott Plesha will present at the Jefferies Global Healthcare Conference on June 4, 2026.Presentation scheduled for 11:05 a.m. ET in New York.Plesha will also hold one-on-one investor meetings at the conference.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL5RC1b8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","IE00BN0W2V16.EUR","SG9999014039.USD","BK4112","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014005.SGD","BK4585","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","BK4139","LU2210150020.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638261215","title":"Pelthos Therapeutics CFO, Treasurer and Secretary Francis Knuettel II disposes of USD 40,265 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2638261215","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638261215?lang=en_us&edition=fundamental","pubTime":"2026-05-27 07:18","pubTimestamp":1779837482,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics CFO, Treasurer, Secretary Francis Knuettel II reported changes tied to his separation, with 13,947 unvested RSUs forfeited for USD 0.Vesting accelerated for 19,525 RSUs, leaving 19,525 shares reported as directly owned following the transaction.Options for 59,500 shares at USD 13.5 became fully vested, lifting his directly held options balance to 59,500.Separately, 1,500 shares were sold from the Lara Knuettel Revocable Trust at an average USD 26.84, leaving 11,316 shares in the trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL27fvHx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pelthos Therapeutics CFO, Treasurer and Secretary Francis Knuettel II disposes of USD 40,265 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638548560","title":"Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX), Bristol-Myers Squibb (BMY) and Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638548560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638548560?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:50","pubTimestamp":1779803408,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on MacroGenics (MGNX), Bristol-Myers Squibb (BMY) and Pelthos Therap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-macrogenics-mgnx-bristol-myers-squibb-bmy-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-macrogenics-mgnx-bristol-myers-squibb-bmy-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836914.USD","LU1670710661.SGD","LU1291159041.SGD","BK4137","PTHS","LU0225284248.USD","LU1261432733.SGD","LU1093756168.USD","LABU","LU1868836757.USD","LU2242646821.SGD","IE00BFXG1179.USD","IE00BJT1NW94.SGD","LU1989771016.USD","LU0882574055.USD","LU0061475181.USD","BK4007","IE0002141913.USD","BK4139","LU1093756325.SGD","LU1868837300.USD","XLV","BK4532","IE00BSNM7G36.USD","LU1430594728.SGD","MGNX","LU1983299246.USD","LU0306806265.USD","LU0868494617.USD","BK4581","LU2242652126.USD","LU0267386448.USD","LU0237698245.USD","IE00B2B36J28.USD","LU2360032135.SGD","IE0009355771.USD","LU1670711123.USD","LU2125154935.USD","HCSG","LU0432979614.USD","LU1883839398.USD","XBI","LU0128526141.USD","BMY","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU0321505439.SGD","LU1074936037.SGD","LU0985481810.HKD","LU1032466523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352001","title":"Pelthos Therapeutics replaces auditor CBIZ with Grant Thornton","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352001","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352001?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397382,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics’ audit committee dismissed CBIZ CPAs as independent registered public accounting firm on May 16, 2026.Grant Thornton was engaged to serve as the new auditor for the fiscal year ending Dec. 31, 2026, covering related interim periods.The audit opinion on the Dec. 31, 2025 financial statements was clean, with no adverse opinion, disclaimer, or qualification.No accounting or auditing disagreements were reported for 2025 and 2024, or for the interim period through May 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDLbbwbR9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635559087","title":"Lake Street Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635559087","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635559087?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:55","pubTimestamp":1778849750,"startTime":"0","endTime":"0","summary":"In a report released today, Ben Haynor from Lake Street maintained a Buy rating on Pelthos Therapeutics, with a price target of $50.00. According t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-reaffirms-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-reaffirms-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635108555","title":"H.C. Wainwright Remains a Buy on Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635108555","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635108555?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:38","pubTimestamp":1778841495,"startTime":"0","endTime":"0","summary":"In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Pelthos Therapeutics, with a price target of $60.00. Fol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635742956","title":"Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS) and Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635742956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635742956?lang=en_us&edition=fundamental","pubTime":"2026-05-15 01:40","pubTimestamp":1778780407,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Keros Therapeutics (KROS) and Pelthos Therapeutics (PTHS). Keros ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-keros-therapeutics-kros-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-keros-therapeutics-kros-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4139","PTHS","BK4137","HCSG","BK4585","BK4588","LU0128526141.USD","KROS","LU0029874061.USD","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635719781","title":"Pelthos Q1 FY26 net loss widens to $10.24 million; revenue rises to $10.91 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635719781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635719781?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:07","pubTimestamp":1778756872,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics posted a net loss of USD 10.24 million for the quarter ended March 31, 2026, widening from a net loss of USD 1.97 million a year earlier.Revenue was USD 10.91 million, including net product revenues of USD 10.67 million from ZELSUVMI sales.Operating loss widened to USD 13.09 million as operating expenses climbed to USD 23.99 million, led by selling, general and administrative costs of USD 21.1 million.Cash totaled USD 32 million at quarter-end, following a USD 30 million borrowing under a senior secured term loan facility that totals up to USD 50 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL2w62Th:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635719344","title":"Pelthos Therapeutics Announces First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635719344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635719344?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA81PWCM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635629719","title":"Pelthos Therapeutics Inc - Q1 2026 Net Loss Narrows to $10.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2635629719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635629719?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA81PWCM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634285233","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2634285233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634285233?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:30","pubTimestamp":1778499051,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pelthos Therapeutics (PTHS), Voyager Therapeutics (V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-159?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-159?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","LU0029874061.USD","LU0128526141.USD","BK4139","BK4581","BK4585","PTHS","BK4137","XBI","VYGR","BLSG","BK4588","BLSX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632614729","title":"Pelthos Therapeutics to report first-quarter results, host conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2632614729","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632614729?lang=en_us&edition=fundamental","pubTime":"2026-05-01 20:30","pubTimestamp":1777638623,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics schedules first-quarter fiscal 2026 financial results for May 14, 2026.Conference call set for 8:30 a.m. ET on May 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL1C9lgG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4112","NDAQ","LU2095319765.USD","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4585","SG9999014013.SGD","LU2210149790.SGD","BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630951933","title":"Alliance Global Partners Keeps Their Buy Rating on Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630951933","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630951933?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:41","pubTimestamp":1777290107,"startTime":"0","endTime":"0","summary":"Alliance Global Partners analyst James Molloy reiterated a Buy rating on Pelthos Therapeutics today and set a price target of $75.00. Molloy covers...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-keeps-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-keeps-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629796317","title":"Pelthos Therapeutics files Form 3 for CFO John M. Gay","url":"https://stock-news.laohu8.com/highlight/detail?id=2629796317","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629796317?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:01","pubTimestamp":1776718883,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics CFO John M. Gay reported 30,518 common shares in an initial Form 3 filing.Filing also listed stock options for 93,000 shares with an exercise price of $13.5.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL5N643x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627446258","title":"Pelthos CEO to hold investor meetings at Piper Sandler Spring Biopharma Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2627446258","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627446258?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:36","pubTimestamp":1776170176,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics CEO Scott Plesha will hold one-on-one investor meetings at Piper Sandler Spring Biopharma Symposium on April 16, 2026 in Boston.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL7Gwkv9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4127","LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","BK4112","NDAQ","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","PIPR","BK4585","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":64,"code":"91000000","status":"200"}]}}